Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-1708
Full Text
Open PDFAbstract
Available in full text
Date
October 3, 2012
Authors
Publisher
American Association for Cancer Research (AACR)